Defunct Company
Total Trials
3
As Lead Sponsor
As Collaborator
0
Total Enrollment
142
NCT00850096
Effects of Nasulin Versus Placebo on Blood Glucose Control in Patient Volunteers With Type 2 Diabetes Mellitus
Phase: Phase 2
Role: Lead Sponsor
Start: Jan 31, 2009
Completion: Mar 31, 2010
NCT00850161
Intranasal Insulin and Its Effect on Postprandial Metabolism in Comparison to Subcutaneous Insulin
Start: Jul 31, 2009
Completion: Sep 30, 2010
NCT04890873
ERX1000 - Safety, Tolerability, Pharmacokinetic, and Pharmacodynamic Study in Male and Female Subjects With Obesity
Phase: Phase 1
Start: Oct 17, 2019
Completion: Jul 3, 2023